Credit: Merck. Supported by the phase 3 CORALreef program, Merck’s once-daily oral macrocyclic peptide offers a non-injectable PCSK9-targeting pathway to significantly clear LDL-C in adults. Lipfendra ...

Clinicians should maintain a high index of suspicion for Cyclospora in patients presenting with prolonged or relapsing watery diarrhea this summer.

Supported by phase 3 SYMPHONY and ENCORE trial data, AXS-12 significantly reduced weekly cataplexy attacks and improved daytime sleepiness and cognition.

At 12 months, adults with insulin-treated diabetes had significant improvements in HbA1c and hospitalizations.

A Prescription Drug User Fee Act target date of February 28, 2027 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

Higher vitamin A is associated with better lung function in children and adults, while vitamin D levels are associated with lower epigenetic aging in asthma in ...

Targeting effective control of rheumatoid arthritis disease activity is crucial component of treatment strategy.

Most US adults using social media report some health-related engagement with social media, according to a research letter published online June 30 in the Journal of the American Medical Association.

The FDA is expected to decide whether to approve an mRNA-based seasonal influenza vaccine for use in adults aged 50 years and older. Moderna’s mRNA-1010 was recently discussed at the Agency’s Vaccines ...

Skyrizi (risankizumab-rzaa) IL-23 inhibitor Treatment of children aged 6 years and older with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy, and for ...